Categories: MedicaidMedicareNews

Lightbeam MSSP Clients Surpass National Averages in Savings, Earnings, and Quality in PY24

Clients leveraging Lightbeam’s Advisory Services achieved the strongest overall results
, averaging $16.6 million in generated savings per ACO and the highest average quality scores in the program

DALLAS, Oct. 21, 2025 /PRNewswire/ — Lightbeam Health Solutions, the proven, AI-enabled solutions and services leader in population health management, today announced that Accountable Care Organizations (ACOs) leveraging Lightbeam solutions in the Medicare Shared Savings Program (MSSP) generated more than $444 million in gross savings in Performance Year (PY) 2024.

Lightbeam clients achieved an average savings rate of 5.02% — higher than the 4.72% achieved by non-Lightbeam ACOs — and produced an average of $16.4 million in generated savings per ACO. Lightbeam-supported ACOs also maintained higher quality scores, with an average score of 83.02% compared to 81.83% for non-Lightbeam ACOs.

Clients partnering with Lightbeam’s Advisory Services realized stronger 2024 results. Advisory-engaged clients generated more than $16.6 million in savings per ACO — the highest among all peer groups — and outperformed non-Lightbeam peers in quality by nearly two percentage points. Lightbeam’s Advisory team partners closely with ACOs to navigate value-based contracts, implement best practices, and accelerate performance improvements.

“These outcomes from our MSSP ACO clients reflect their ongoing collaboration, commitment, and focus on delivering high-quality care — improving patient satisfaction and reducing total cost of care,” said Melissa Tyler, Vice President of Advisory Services at Lightbeam. “We remain committed to advancing value-based care by meeting clients where they are and applying data-driven strategies — including remote patient monitoring (RPM), artificial intelligence (AI), and targeted care gap interventions — to close gaps and improve outcomes for our clients and the patients they serve.”

Building on the $3 billion in gross MSSP savings and $5 billion in total value-based care savings since program inception, Lightbeam continues to partner with ACOs nationwide to achieve meaningful outcomes at scale.

For more information on how Lightbeam empowers ACOs in the MSSP, visit our website or request a demo.

About Lightbeam Health Solutions

Lightbeam Health is a proven, AI-enabled platform, solutions, and services leader for population health management. Lightbeam’s AI-enabled population health platform arms payers and providers with the data-driven solutions and services they need to facilitate care orchestration and improve patient outcomes while finding success in all value-based arrangements. Lightbeam Health services ACO REACH, MSSP ACO, Medicare Advantage, traditional Medicare, Medicaid, and commercial populations across the country. For more information, visit www.lightbeamhealth.com and follow Lightbeam on LinkedIn and X (Twitter).

Lightbeam Health Contact:
Amanda Hunt
media@lightbeamhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lightbeam-mssp-clients-surpass-national-averages-in-savings-earnings-and-quality-in-py24-302590148.html

SOURCE Lightbeam Health Solutions

Staff

Recent Posts

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

52 minutes ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

53 minutes ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

4 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

7 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

7 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

7 hours ago